Pancancer analysis shows immune and epithelial interactions shaping liver metastasis, suggesting new treatment targets.
Liver metastasis is a frequent and clinically important event across multiple solid tumors, yet a cross-cancer single-cell description of the metastatic immune ecosystem remains incomplete. Here, we integrated single-cell RNA-sequencing data from primary tumors and liver metastases across 12 cancer types and combined cell-state annotation, pseudotime ordering, ligand–receptor inference, and multiplex immunofluorescence as orthogonal tissue-level support. We identified a hepatocyte-like malignant epithelial state enriched in liver metastases, characterized by coexpression of hepatic genes, epithelial markers, oncogenic transcripts such as MYC and KRAS, and inferred copy-number-variation signals. CellChat analysis suggested that this epithelial state may engage RGS1-high and LILRB5-high macrophage states through a CCL3–CCR1-associated signaling axis. Reprocessed tissue imaging supported spatial proximity between TAT+/EPCAM+ epithelial cells and these macrophage populations across several tumor types. In addition, macrophage and T-cell composition differed between primary tumors and liver metastases, and sample-level associations linked RGS1-high macrophages to selected CD4 + T-cell states and LILRB5-high resident-like macrophages to selected CD8 + T-cell states. Overall, this study provides a pancancer descriptive atlas of epithelial–immune programs associated with liver metastasis and nominates candidate cellular associations for future functional testing.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: